REGISTERED NUMBER: 16129778 (England and Wales)

Unaudited Financial Statements

for the Period 11 December 2024 to 31 December 2025

for

Medical Gold Ltd

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

3

DIRECTORS:

A Alaya

Dr R Awadzi

REGISTERED OFFICE:

197c St. Pauls Avenue

Harrow

HA3 9PT

REGISTERED NUMBER:

16129778 (England and Wales)

ACCOUNTANTS:

HATS Gloucester Ltd

48 Hucclecote Road

Gloucester

Gloucestershire

GL3 3RS

FIXED ASSETS

Tangible assets

4

6,655

CURRENT ASSETS

Debtors

5

257

Cash at bank

1,986

2,243

CREDITORS

Amounts falling due within one year

6

4,550

NET CURRENT LIABILITIES

(2,307

)

TOTAL ASSETS LESS CURRENT LIABILITIES

4,348

CAPITAL AND RESERVES

Called up share capital

7

2

Retained earnings

4,346

SHAREHOLDERS' FUNDS

4,348

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 August 2026 and were signed on its behalf by:

A Alaya - Director

Dr R Awadzi - Director

1.	STATUTORY INFORMATION

Medical Gold Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on cost

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Going concern

Despite net current liabilities of £2,307 on 31 December 2025, the accounts have been prepared on a going concern basis. The directors have reviewed future cash flows of the business and expressed their willingness to financially support the company for the foreseeable future and therefore considers it appropriate to prepare the financial statements on a going concern basis.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

Cost

Additions

7,370

At 31 December 2025

7,370

Depreciation

Charge for period

715

At 31 December 2025

715

Net book value

At 31 December 2025

6,655

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Other debtors

257

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Amounts owed to group undertakings

3,393

Other creditors

1,157

4,550

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

value:

£

2

Ordinary

£1

2

2 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 December 2025:

£

Dr R Awadzi

Balance outstanding at start of period

-

Amounts advanced

68

Amounts repaid

-

Amounts written off

-

Amounts waived

-

Balance outstanding at end of period

68

The above loan to the director, included within other debtors, is repaid within 9 months of the year end.

9.	RELATED PARTY DISCLOSURES

Kadir Gold Ltd

A company controlled by the director A Alaya

Included in other creditors is a loan from Kadir Gold Ltd of £3,393. The unsecured loan is interest free with no fixed repayment terms.

Getmedical Ltd

A company controlled by the director R Awadzi.

During the period, the company invoiced Getmedical Ltd £8,999 which was all paid up by the year end. The transactions were all on an arms length basis.